Lipid lowering effects of statins and fibrates in the management of HIV dyslipidemias associated with antiretroviral therapy in HIV clinical practice.

MLA

Visnegarwala, Fehmida, et al. “Lipid Lowering Effects of Statins and Fibrates in the Management of HIV Dyslipidemias Associated with Antiretroviral Therapy in HIV Clinical Practice.” The Journal of Infection, vol. 49, no. 4, Nov. 2004, pp. 283–90. EBSCOhost, https://doi.org/10.1016/j.jinf.2003.09.006.

APA

Visnegarwala, F., Maldonado, M., Sajja, P., Minihan, J. L., Rodriguez-Barradas, M. C., Ong, O., Lahart, C. J., Hasan, M. Q., Balasubramanyam, A., & White, A. C., Jr. (2004). Lipid lowering effects of statins and fibrates in the management of HIV dyslipidemias associated with antiretroviral therapy in HIV clinical practice. The Journal of Infection, 49(4), 283–290. https://doi.org/10.1016/j.jinf.2003.09.006

Chicago

Visnegarwala, Fehmida, Mario Maldonado, Prasuna Sajja, Jennifer L Minihan, Maria C Rodriguez-Barradas, Oliver Ong, Christopher J Lahart, Mirza Qasim Hasan, Ashok Balasubramanyam, and A Clinton White Jr. 2004. “Lipid Lowering Effects of Statins and Fibrates in the Management of HIV Dyslipidemias Associated with Antiretroviral Therapy in HIV Clinical Practice.” The Journal of Infection 49 (4): 283–90. doi:10.1016/j.jinf.2003.09.006.